Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation

Journal of Clinical Virology

Volumn 54, Issue 2, 2012, Pages 152-155

  Abravanel, Florence ^a,b   Mansuy, Jean Michel ^b   Huynh, Anne ^b   Kamar, Nassim ^a,c   Alric, Laurent ^b   Peron, Jean Marie ^b   Récher, Christian ^b   Izopet, Jacques ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c CHU RANGUEIL   (France)

Author keywords

Hepatitis E virus; Prevalence; Reactivation; Stem cell transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOSPORIN A; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VIRUS RNA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY DETECTION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; CYTOMEGALOVIRUS; FEMALE; FRANCE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; SIDE EFFECT; VIRUS DETECTION; VIRUS REACTIVATION;

ADULT; FEMALE; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RNA, VIRAL; VIRUS ACTIVATION;

EID: 84860322521     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.02.015     Document Type: Article

References (35)

1. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
2. Khuroo M.S., Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003, 10:61-69.
3. Dalton H.R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007, 369:1260.
4. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14:298-303.
5. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008, 358:859-860.
6. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
7. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
8. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009, 150:430-431.
9. Peron J.M., Mansuy J.M., Recher C., Bureau C., Poirson H., Alric L., et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006, 21:1223-1224.
10. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
11. Kenfak-Foguena A., Schoni-Affolter F., Burgisser P., Witteck A., Darling K.E., Kovari H., et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
12. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
13. le Coutre P., Meisel H., Hofmann J., Rocken C., Vuong G.L., Neuburger S., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
14. Baylis S.A., Hanschmann K.M., Blumel J., Nubling C.M. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011, 49:1234-1239.
15. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
16. Alric L., Bonnet D., Laurent G., Kamar N., Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010, 153:135-136.
17. Mansuy J.M., Huynh A., Abravanel F., Recher C., Peron J.M., Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009, 48:373-374.
18. Tavitian S., Peron J.M., Huynh A., Mansuy J.M., Ysebaert L., Huguet F., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010, 49:141-144.
19. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
20. Mengelle C., Legrand-Abravanel F., Mansuy J.M., Barthe C., Da Silva I., Izopet J. Comparison of two highly automated DNA extraction systems for quantifying Epstein-Barr virus in whole blood. J Clin Virol 2008, 43:272-276.
21. Mengelle C., Sandres-Saune K., Pasquier C., Rostaing L., Mansuy J.M., Marty M., et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 2003, 41:3840-3845.
22. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
23. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
24. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
25. Kamar N., Mansuy J.M., Cointault O., Selves J., Abravanel F., Danjoux M., et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008, 8:1744-1748.
26. Labadie K., Larcher T., Joubert C., Mannioui A., Delache B., Brochard P., et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010, 120:894-906.
27. Way S.J., Lidbury B.A., Banyer J.L. Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology 2002, 301:281-292.
28. Hoarau J.J., Jaffar Bandjee M.C., Krejbich Trotot P., Das T., Li-Pat-Yuen G., Dassa B., et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010, 184:5914-5927.
29. Lanford R.E., Feng Z., Chavez D., Guerra B., Brasky K.M., Zhou Y., et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci USA 2011, 108:11223-11228.
30. Ippagunta S.K., Naik S., Jameel S., Ramana K.N., Aggarwal R. Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients. J Viral Hepat 2011, 18:668-672.
31. Schlosser B., Stein A., Neuhaus R., Pahl S., Ramez B., Kruger D.H., et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2011, 56:500-502.
32. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
33. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010, 139:1612-1618.
34. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Lhomme S., Mansuy J.M., Muscari F., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
35. Tamura A., Shimizu Y.K., Tanaka T., Kuroda K., Arakawa Y., Takahashi K., et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007, 37:113-120.